Disclosed are N-[Phenyl(alkyl-2-piperidyllmethyl]benzamide derivatives, corresponding to the general formula (I), wherein the variables shown in this formula are as defined in the specification. Also disclosed are their processes of preparation. The compounds are used as therapeutic agents for treating behavioural disorders associated with dementia, psychoses, various forms of anxiety, panic attacks, phobias, obsessive compulsive disorders, various forms of depression, disorders caused by alcohol abuse or weaning from alcohol, sexual behaviour disorders, eating disorders, migraine, contracture, pain, Parkinson's disease and Parkinson-like symptoms, epilepsy, mixed forms and other epileptic syndromes in addition to another antiepileptic treatment, or in monotherapy, and sleep apnea, and for neuroprotection.
Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics